Impaired type I IFN-induced Jak/STAT signaling in FA-C cells and abnormal CD4+ Th cell subsets in Fancc-/- mice

Journal of Immunology

Volumn 173, Issue 6, 2004, Pages 3863-3870

  Fagerlie, Sara R ^a,c   Koretsky, Tara ^a   Torok Storb, Beverly ^c   Bagby, Grover C ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INTERFERON; JANUS KINASE; STAT PROTEIN; STAT1 PROTEIN;

ANIMAL CELL; ARTICLE; B LYMPHOBLAST; FANCONI ANEMIA; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

EID: 4644273869     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.6.3863     Document Type: Article

References (75)

1. D'Andrea, A. D., and M. Grompe. 1997. Molecular biology of Fanconi anemia: Implications for diagnosis and therapy. Blood 90:1725.
2. Rosenberg, P. S., M. H. Greene, and B. P. Alter. 2003. Cancer incidence in persons with Fanconi anemia. Blood 101:822.
3. Bagby, G. C., Jr. 2003. Genetic basis of Fanconi anemia. Curr. Opin. Hematol. 10:68.
4. Kutler, D. I., V. B. Wreesmann, A. Goberdhan, L. Ben Porat, J. Satagopan, I. Ngai, A. G. Huvos, P. Giampietro, O. Levran, K. Pujara, et al. 2003. Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. J. Natl. Cancer Inst. 95:1718.
5. Carvalho, J. P., M. L. Dias, F. M. Carvalho, D. M. Pilar Estevez, and I. W. Petito. 2002. Squamous cell vulvar carcinoma associated with Fanconi's anemia: a case report. Int. J. Gynecol. Cancer 12:220.
6. Somers, G. R., S. N. Tabrizi, K. Tiedemann, C. W. Chow, S. M. Garland, and D. J. Venter. 1995. Squamous cell carcinoma of the tongue in a child with Fanconi anemia: a case report and review of the literature. Pediatr. Pathol. Lab. Med. 15:597.
7. Kaplan, M. J., H. Sabio, H. J. Wanebo, and R. W. Cantrell. 1985. Squamous cell carcinoma in the immunosuppressed patient: Fanconi's anemia. Laryngoscope 95:771.
8. Johansson, E., K. M. Niemi, M. Siimes, and S. Pyrhonen. 1982. Fanconi's anemia: tumor-like warts, hyperpigmentation associated with deranged keratinocytes, and depressed cell-mediated immunity. Arch. Dermatol. 118:249.
9. Froom, P., E. Aghai, J. B. Dobinsky, M. Quitt, and N. Lahat. 1987. Reduced natural killer activity in patients with Fanconi's anemia and in family members. Leuk. Res. 11:197.
10. Pedersen, F. K., H. Hertz, C. Lundsteen, P. Platz, and M. Thomsen. 1977. Indication of primary immune deficiency in Fanconi's anemia. Acta Paediatr. Scand. 66:745.
11. Standen, G. R., I. A. Hughes, A. D. Geddes, B. M. Jones, and C. A. Wardrop. 1989. Myelodysplastic syndrome with trisomy 8 in an adolescent with Fanconi anemia and selective IgA deficiency. Am. J. Hematol. 31:280.
12. Castello, G., C. Gallo, M. Napolitano, and P. A. Ascierto. 1998. Immunological phenotype analysis of patients with Fanconi's anemia and their family members. Acta Haematol. 100:39.
13. MacMillan, M. L., A. D. Auerbach, S. M. Davies, T. E. Defor, A. Gillio, R. Giller, R. Harris, M. Cairo, K. Dusenbery, B. Hirsch, et al. 2000. Hematopoietic cell transplantation in patients with Fanconi anemia using alternate donors: results of a total body irradiation dose escalation trial. Br. J. Haematol. 109:121.
14. Gluckman, E., A. Auerbach, R. C. Ash, J. C. Biggs, M. M. Bortin, B. M. Camitta, R. E. Champlin, W. Friedrich, R. P. Gale, and R. A. Good. 1992. Allogeneic bone marrow transplants for Fanconi anemia: a preliminary report from the International Bone Marrow Transplant Registry. Bone Marrow Transplant. 10(Suppl. 1):53.
15. Lo, T. F., Jr., M. A. Rooimans, L. Bosnoyan-Collins, N. Alon, M. Wijker, L. Parker, J. Lightfoot, M. Carreau, D. F. Callen, A. Savoia, et al. 1996. Expression cloning of a cDNA for the major Fanconi anemia gene, FAA. Nat. Genet. 14:320.
16. Strathdee, C. A., H. Gavish, W. R. Shannon, and M. Buchwald. 1992. Cloning of cDNAs for Fanconi's anemia by functional complementation. [Published erratum appears in 1992 Nature 358:434.] Nature 356:763.
17. Strathdee, C. A., H. Gavish, W. R. Shannon, and M. Buchwald. 1992. Cloning of cDNAs for Fanconi's anemia by functional complementation. [Published erratum appears in 1992 Nature 358:434.] Nature 356:763.
18. Howlett, N. G., T. Taniguchi, S. Olson, B. Cox, Q. Waisfisz, C. Die-Smulders, N. Persky, M. Grompe, H. Joenje, G. Pals, et al. 2002. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297:606.
19. Timmers, C., T. Taniguchi, J. Hejna, C. Reifsteck, L. Lucas, D. Bruun, M. Thayer, B. Cox, S. Olson, A. D. D'Andrea, et al. 2001. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol. Cell 7:241.
20. De Winter, J. P., F. Leveille, C. G. van Berkel, M. A. Rooimans, L. van der Weel, J. Steltenpool, I. Demuth, N. V. Morgan, N. Alon, L. Bosnoyan-Collins, et al. 2000. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am. J. Hum. Genet. 67:1306.
21. De Winter, J. P., W. L. van der, J. de Groot, S. Stone, Q. Waisfisz, F. Arwert, R. J. Scheper, F. A. Kruyt, M. E. Hoatlin, and H. Joenje. 2000. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum. Mol. Genet. 9:2665.
22. Liu, N., J. E. Lamerdin, J. D. Tucker, Z. Q. Zhou, C. A. Walter, J. S. Albala, D. B. Busch, and L. H. Thompson. 1997. The human XRCC9 gene corrects chromosomal instability and mutagen sensitivities in CHO UV40 cells. Proc. Natl. Acad. Sci. USA 94:9232.
23. Meetei, A. R., J. P. de Winter, A. L. Medhurst, M. Wallisch, Q. Waisfisz, H. J. van de Vrugt, A. B. Oostra, Z. Yan, C. Ling, C. E. Bishop, et al. 2003. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet. 35:165.
24. De Winter, J. P., Q. Waisfisz, M. A. Rooimans, C. G. van Berkel, L. Bosnoyan-Collins, N. Alon, M. Carreau, O. Bender, I. Demuth, D. Schindler, et al. 1998. The Fanconi anemia group G gene FANCG is identical with XRCC9. Nat. Genet. 20:281.
25. Garcia-Higuera, I., T. Taniguchi, S. Ganesan, M. S. Meyn, C. Timmers, J. Hejna, M. Grompe, and A. D. D'Andrea. 2001. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7:249.
26. Pang, Q., S. Fagerlie, T. A. Christianson, W. Keeble, G. Faulkner, J. Diaz, R. K. Rathbun, and G. C. Bagby. 2000. The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by γ interferon and hematopoietic growth factors. Mol. Cell. Biol. 20:4724.
27. Fagerlie, S. R., J. Diaz, T. A. Christianson, K. McCartan, W. Keeble, G. R. Faulkner, and G. C. Bagby. 2001. Functional correction of FA-C cells with FANCC suppresses the expression of interferon γ-inducible genes. Blood 97:3017.
28. Takaoka, A., Y. Mitani, H. Suemori, M. Sato, T. Yokochi, S. Noguchi, N. Tanaka, and T. Taniguchi. 2000. Cross talk between interferon-γ and -α/β signaling components in caveolar membrane domains. Science 288:2357.
29. Karaghiosoff, M., H. Neubauer, C. Lassnig, P. Kovarik, H. Schindler, H. Pircher, B. McCoy, C. Bogdan, T. Decker, G. Brem, et al. 2000. Partial impairment of cytokine responses in Tyk2-deficient mice. Immunity 13:549.
30. Rathbun, R. K., G. R. Faulkner, M. H. Ostroski, T. A. Christianson, G. Hughes, G. Jones, R. Cahn, R. Maziarz, G. Royle, W. Keeble, et al. 1997. Inactivation of the Fanconi anemia group C gene augments interferon-γ- induced apoptotic responses in hematopoietic cells. Blood 90:974.
31. Whitney, M. A., G. Royle, M. J. Low, M. A. Kelly, M. K. Axthelm, C. Reifsteck, S. Olson, R. E. Braun, M. C. Heinrich, R. K. Rathbun, et al. 1996. Germ cell defects and hematopoietic hypersensitivity to γ-interferon in mice with a targeted disruption of the Fanconi anemia C gene. Blood 88:49.
32. Jakobs, P. M., P. Sahaayaruban, H. Saito, C. Reifsteck, S. Olson, H. Joenje, R. E. Moses, and M. Grompe. 1996. Immortalization of four new Fanconi anemia fibroblast cell lines by an improved procedure. Somatic Cell Mol. Genet. 22:151.
33. Shimoda, K., K. Kato, K. Aoki, T. Matsuda, A. Miyamoto, M. Shibamori, M. Yamashita, A. Numata, K. Takase, S. Kobayashi, et al. 2000. Tyk2 plays a restricted role in IFN α signaling, although it is required for IL-12-mediated T cell function. Immunity 13:561.
34. Grusby, M. J. 1997. Stat4- and Stat6-deficient mice as models for manipulating T helper cell responses. Biochem. Soc. Trans. 25:359.
35. Taniguchi, T., and A. Takaoka. 2001. A weak signal for strong responses: interferon-α/β revisited. Nat. Rev. Mol. Cell Biol. 2:378.
36. Tanaka, N., M. Sato, M. S. Lamphier, H. Nozawa, E. Oda, S. Noguchi, R. D. Schreiber, Y. Tsujimoto, and T. Taniguchi. 1998. Type I interferons are essential mediators of apoptotic death in virally infected cells. Genes Cells 3:29.
37. Kumaran, I., O. R. Colamonici, and E. N. Fish. 2000. Structure-Function study of the extracellular domain of the human type I interferon receptor (IFNAR)-1 subunit. J. Interferon Cytokine Res. 20:479.
38. Prejean, C., and O. R. Colamonici. 2000. Role of the cytoplasmic domains of the type I interferon receptor subunits in signaling. Semin. Cancer Biol. 10:83.
39. Park, C., S. Li, E. Cha, and C. Schindler. 2000. Immune response in Stat2 knockout mice. Immunity 13:795.
40. Wong, A. H., N. W. Tam, Y. L. Yang, A. R. Cuddihy, S. Li, S. Kirchhoff, H. Hauser, T. Decker, and A. E. Koromilas. 1997. Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways. EMBO J. 16:1291.
41. Pang, Q., T. A. Christianson, W. Keeble, T. Koretsky, and G. C. Bagby. 2002. The anti-apoptotic function of Hsp70 in the interferon-inducible double-stranded RNA-dependent protein kinase-mediated death signaling pathway requires the Fanconi anemia protein, FANCC. J. Biol. Chem. 277:49638.
42. Pang, Q., W. Keeble, T. A. Christianson, G. R. Faulkner, and G. C. Bagby. 2001. FANCC interacts with Hsp70 to protect hematopoietic cells from IFN-γ/TNF-α-mediated cytotoxicity. EMBO J. 20:4478.
43. Diehl, S., J. Anguita, A. Hoffmeyer, T. Zapton, J. N. Ihle, E. Fikrig, and M. Rincon. 2000. Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. Immunity 13:805.
44. Todryk, S., A. A. Melcher, N. Hardwick, E. Linardakis, A. Bateman, M. P. Colombo, A. Stoppacciaro, and R. G. Vile. 1999. Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J. Immunol. 163:1398.
45. Hoatlin, M. E., Y. Zhi, H. Ball, K. Silvey, A. Melnick, S. Stone, S. Arai, N. Hawe, G. Owen, A. Zelent, and J. D. Licht. 1999. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF. Blood 94:3737.
46. Miaw, S. C., A. Choi, E. Yu, H. Kishikawa, and I. C. Ho. 2000. ROG, repressor of GATA, regulates the expression of cytokine genes. Immunity 12:323.
47. Farrar, J. D., and K. M. Murphy. 2000. Type I interferons and T helper development. Immunol. Today 21:484.
48. Agarwal, S., and A. Rao. 1998. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 9:765.
49. Qiao, F., A. Moss, and G. M. Kupfer. 2001. Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner. J. Biol. Chem. 276:23391.
50. Rengarajan, J., S. J. Szabo, and L. H. Glimcher. 2000. Transcriptional regulation of Th1/Th2 polarization. Immunol. Today 21:479.
51. Broxmeyer, H. E., H. A. Bruns, S. Zhang, S. Cooper, G. Hangoc, A. N. McKenzie, A. L. Dent, U. Schindler, L. K. Naeger, T. Hoey, and M. H. Kaplan. 2002. Th1 cells regulate hematopoietic progenitor cell homeostasis by production of oncostatin M. Immunity 16:815.
52. Charlton, B., and K. J. Lafferty. 1995. The Th1/Th2 balance in autoimmunity. Curr. Opin. Immunol. 7:793.
53. Fujisao, S., and H. Tsuda. 1998. Th1/Th2 balance alteration in the clinical course of a patient with pure red cell aplasia and thymoma. Br. J. Haematol. 103:308.
54. Infante-Duarte, C., and T. Kamradt. 1999. Th1/Th2 balance in infection. Springer Semin. Immunopathol. 21:317.
55. Kerttula, T. O., P. Collin, M. Maki, and M. Hurme. 1999. Normal T-helper 1/T-helper 2 balance in peripheral blood of coeliac disease patients. Scand. J. Immunol. 49:197.
56. Akahoshi, M., H. Nakashima, Y. Tanaka, T. Kohsaka, S. Nagano, E. Ohgami, Y. Arinobu, K. Yamaoka, H. Niiro, M. Shinozaki, et al. 1999. Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum. 42:1644.
57. Kelly, J. M., P. K. Darcy, J. L. Markby, D. I. Godfrey, K. Takeda, H. Yagita, and M. J. Smyth. 2002. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat. Immunol. 3:83.
58. Reizenstein, P., C. Ogier, H. Blomgren, B. Petrini, and J. Wasserman. 1985. Cells responsible for tumor surveillance in man: effects of radiotherapy, chemotherapy, and biologic response modifiers. Adv. Immun. Cancer Ther. 1:1.
59. Persing, D. H., and F. G. Prendergast. 1999. Infection, immunity, and cancer. Arch. Pathol. Lab. Med. 123:1015.
60. + T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix. Gynecol. Oncol. 81:424.
61. Clerici, M., E. Clerici, and G. M. Shearer. 1996. The tumor enhancement phenomenon: reinterpretation from a Th1/Th2 perspective. J. Natl. Cancer Inst. 88:461.
62. Tahara, H., and M. T. Lotze. 1995. Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer. Gene Ther. 2:96.
63. Osaki, T., J. M. Peron, Q. Cai, H. Okamura, P. D. Robbins, M. Kurimoto, M. T. Lotze, and H. Tahara. 1998. IFN-γ-inducing factor/IL-18 administration mediates IFN-γ- and IL-12-independent antitumor effects. J. Immunol. 160:1742.
64. Coughlin, C. M., K. E. Salhany, M. S. Gee, D. C. LaTemple, S. Kotenko, X. Ma, G. Gri, M. Wysocka, J. E. Kim, L. Liu, et al. 1998. Tumor cell responses to IFNγ affect tumorigenicity and response to IL-12 therapy and antiangiogenesis. Immunity 9:25.
65. Kaplan, D. H., V. Shankaran, A. S. Dighe, E. Stockert, M. Aguet, L. J. Old, and R. D. Schreiber. 1998. Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA 95:7556.
66. Alter, B. P. 1996. Fanconi's anemia and malignancies. Am. J. Hematol. 53:99.
67. Alter, B. P., M. H. Greene, I. Velazquez, and P. S. Rosenberg. 2003. Cancer in Fanconi anemia. Blood 101:2072.
68. Alter, B. P. 2003. Cancer in Fanconi anemia, 1927-2001. Cancer 97:425.
69. Paz, I. B., N. Cook, T. Odom-Maryon, Y. Xie, and S. P. Wilczynski. 1997. Human papillomavirus (HPV) in head and neck cancer: an association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 79:595.
70. Chang, F., S. Syrjanen, Q. Shen, H. X. Ji, and K. Syrjanen. 1990. Human papillomavirus (HPV) DNA in esophageal precancer lesions and squamous cell carcinomas from China. Int. J. Cancer 45:21.
71. Gissmann, L. 1989. Linking HPV to cancer. Clin. Obstet. Gynecol. 32:141.
72. Campo, M. S. 1998. HPV and cancer: the story unfolds. Trends Microbiol. 6:424.
73. + lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer. J. Virol. 73:5402.
74. Van der Burg, S. H., M. E. Ressing, K. M. Kwappenberg, A. de Jong, K. Straathof, J. de Jong, A. Geluk, K. E. van Meijgaarden, K. L. Franken, T. H. Ottenhoff, et al. 2001. Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopes. Int. J. Cancer 91:612.
75. Shankaran, V., H. Ikeda, A. T. Bruce, J. M. White, P. E. Swanson, L. J. Old, and R. D. Schreiber. 2001. IFN-γ and lymphocytes prevent primary tumor development and shape tumor immunogenicity. Nature 410:1107.